Skip to main content

Transforming specialty pharmacy care

More patients are living with complex and chronic conditions. We can help. At Optum Specialty Pharmacy, we support you and your patients every step of the way. 

Get started

Working every day to make specialty pharmacy easier for you and your patients.

  

Specialty medication is expensive — so we're looking for savings.

We connect patients with all available financial resources, making it easier to afford their medications.​

Prescription processes are too complex — so we're making them simpler.​

Our services and support save you time so you can spend it with your patients.  

Pharmacy systems are too impersonal — so we're tailoring our approach.

Our approach includes real people providing solutions to ensure you and your patients' unique needs are met. ​

  

Our Centers of Excellence deliver patient-first care management

Delivering a better care experience

Putting patients first with expert support

Patients receive hands-on support from our pharmacists, patient care coordinators and others who are experts in complex conditions.

Result: 86.4% of patients participating in Optum oncology patient programs report higher quality of life during clinician follow-ups.1,2

Better access and lower out-of-pocket costs

Optum Savings IQTM helps connect patients with all available financial resources to help pay for their medication.

Result: In 2023, patients had a $5 median copay3 and we saw 89% fewer order cancellations from patients due to financial reasons4.

Streamlined prior authorizations and appeals made easy

Prior authorizations (PA) can take time that could be better spent on patient care.

Result: With a smoother process, more than 33% of PAs receive a plan determination in less than 24 hours.5 We can help you with appeals too – our appeals team overturns more than 8 out of 10 denials.6

A new approach to care

Our Centers of Excellence for oncology, neurology, immunology, gastroenterology and cardiopulmonary conditions deliver a specialized care experience focused on clinical outcomes.

Result: 100% access to medications to cover days on therapy for patients enrolled in Schedule My Fill.7

Digital tools and unwavering advocacy

Your patients have free access to a variety of tools, including Optum Connections, a collection of digital tools and resources to help them manage their condition.

Result: Patients who used the patient portal were up to 16% more persistent in therapy.*

Provider portal and EMR solutions

Our digital tools provide access to detailed patient information and make it easier to manage your patients’ medications.

Result: Optum provider portal users connect with the Optum team via chat within 23 seconds on average.8 And for even easier prescribing, EMR Task processes prescriptions an average of 17 hours faster, which improves the ship rate by 30%.9

Partner with us

At Optum, we are dedicated to partnering with you to improve patient outcomes and make specialty pharmacy care more efficient and effective. Let’s work together to transform the way we care for your patients.

Sources

1. Optum Specialty Pharmacy. Yearly oncology clinical management review. January 1–December 31, 2023.​
2. Facit. FACT-G7. The Functional Assessment of Cancer Therapy – General – 7 Item Version. Data captured using the FACT-G7 survey, a validated oncology-specific health-related patient reported outcome measurement (PROM) tool for advanced cancers. 2023.​
3. Optum Specialty Pharmacy, Financial Assistance Dashboard. Available claims only, 1/1/2024–5/31/2024.
4. Optum Specialty Pharmacy. Financial assistance book of business. 2023.​
5. Optum Specialty Pharmacy prior authorization data. November 2023.​
6. Optum Specialty Pharmacy appeals data. 2023.​
7. Optum Specialty Pharmacy. Impact of Schedule My Fill on medication adherence and persistence among patients. April 1–December 2023.
8. Optum. Internal analysis. January–September 2023. ​
9. Optum. Optum EMR dashboard report. December 22, 2022–July 25, 2023​
* Optum Specialty Pharmacy. Internal patient portal user analysis. 2024.